CLINICAL_TRIALS
trial_result
· 2023-05-18
Clinical Trial Update: High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma [Phase 2]
Summary
Phase 2 clinical trial update on high-dose BeEAM chemotherapy with autologous transplant in multiple myeloma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northside Hospital, Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-18